Kilitch Drugs Reports Strong Growth Amid Challenges in Management Efficiency - MarketsMojo
Yesterday • Google News
Kilitch Drugs (India) Limited (KILITCH)
NSEINR 441.75-0.07%
Price Chart
Key Statistics
Market Cap
INR 7.15B
P/E Ratio
26.78
Revenue (TTM)
INR 1.98B
Volume
8.44K
52W High
INR 499.00
52W Low
INR 299.95
Dividend Yield
0.00%
Beta
-0.24
Technicals
50-Day MA
421.443
200-Day MA
352.1453
52 Week High
499
52 Week Low
299.95
About KILITCH
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, non-steroidal .
Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Mukund Prataprai Mehta B.Com., LL.B.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg